Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $35.67 $43.20 Thursday, 9th May 2024 CLDX stock ended at $41.06. This is 0.364% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.12% from a day low at $41.01 to a day high of $41.88.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Sep 15, 2016 $55.50 $55.80 $54.00 $55.50 71 047
Sep 14, 2016 $54.30 $55.65 $54.15 $55.35 114 300
Sep 13, 2016 $54.90 $54.90 $51.90 $53.70 121 120
Sep 12, 2016 $51.60 $55.95 $51.60 $55.65 210 840
Sep 09, 2016 $55.35 $55.80 $51.75 $51.75 111 767
Sep 08, 2016 $55.35 $55.95 $53.55 $55.65 125 580
Sep 07, 2016 $52.95 $55.35 $52.95 $54.90 120 460
Sep 06, 2016 $50.55 $53.40 $49.80 $52.95 260 127
Sep 02, 2016 $50.25 $50.70 $48.45 $50.25 80 967
Sep 01, 2016 $49.65 $50.55 $48.90 $50.40 79 993
Aug 31, 2016 $51.15 $51.30 $49.35 $49.80 114 753
Aug 30, 2016 $52.05 $52.95 $50.40 $51.45 98 740
Aug 29, 2016 $55.50 $55.50 $51.15 $52.20 56 380
Aug 26, 2016 $52.80 $52.80 $50.85 $52.35 132 713
Aug 25, 2016 $53.25 $54.60 $50.40 $52.05 145 127
Aug 24, 2016 $56.70 $58.20 $52.50 $52.50 182 627
Aug 23, 2016 $58.80 $60.15 $56.70 $56.70 192 787
Aug 22, 2016 $59.25 $61.05 $57.90 $58.50 376 440
Aug 19, 2016 $62.25 $62.25 $57.60 $59.25 603 220
Aug 18, 2016 $64.20 $65.25 $62.10 $62.40 167 893
Aug 17, 2016 $66.00 $66.30 $64.05 $64.05 87 080
Aug 16, 2016 $66.75 $67.95 $65.85 $66.30 110 960
Aug 15, 2016 $66.90 $68.40 $66.75 $66.90 94 480
Aug 12, 2016 $65.25 $67.50 $64.80 $66.90 84 147
Aug 11, 2016 $68.10 $68.85 $65.10 $65.40 176 393
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT